Archive | Innovation Challenge RSS feed for this section

Digital RESI June 2020: Innovation Challenge Finalists Announced!

21 May

By Claire Jeong, Vice President of Investor Research, Asia BD, LSN

claireOur 3-day Digital RESI June Conference is coming up in less than 3 weeks, and we are very excited to announce our Innovation Challenge finalists. With a diverse representation across therapeutics, medical devices, diagnostics, and digital health, these companies were selected on the basis of innovative technology, strong management team, clear pathway to commercialization, and other positive factors that demonstrated high growth potential.

This will be our second time organizing a “digital” Innovation Challenge, and each company will have a dedicated webpage as part of our virtual conference agenda. These pages will feature a virtual poster and any non-confidential materials they would like to share with the conference attendees. Attendees will be able to vote for their favorite technologies during the 3-day span, and the Top 3 winners will be announced at the end of the conference and featured on our weekly LSN newsletter of 36,000 subscribers on Thursday.

We would like to thank all applicants for their interest in the upcoming RESI and our Innovation Challenge. Congratulations to the selected finalists – please see their clickable logos below!

Therapeutics

Medical Devices

Diagnostics

Digital Health

Apply for the Digital RESI Innovation Challenge

16 Apr

By Karen Deyo, Senior Investor Research Analyst, LSN

Our Digital RESI taking place on June 8-10th is just around the corner, and companies will once again be able to showcase their technologies through the RESI Innovation Challenge. Companies can apply to participate, and the review team will use the LSN Expert System to select the 30 most ‘investable’ companies to be featured. Each company will have their own dedicated site to present their poster digitally, as well as any other non-confidential material they wish to share. These companies will compete for votes among RESI attendees, with the top three companies winning prizes. Click here to complete the application. Don’t wait too long, as the application deadline is May 6th!

 

 

 

 

RESI Europe 2020 Innovation Challenge – Check Out the Finalists!

5 Mar

By Claire Jeong, Director of Research, Asia BD, LSN

claire

With less than 3 weeks left until our second RESI Europe conference, we are very excited to announce the RESI Europe Innovation Challenge finalists. The RESI team received applications from all across the globe, boasting an even stronger diversity than our inaugural RESI Europe in Vienna last year.

All registered RESI attendees will receive 5 “RESI Cash”, which they can use to “invest” in the most promising Innovation Challenge companies. As always, we highly encourage all attendees to reserve some time during the conference to browse around the exhibit hall and engage with the finalists who will be eager to pitch their company and the innovative work they are doing to address unmet medical needs.

Thank you for everyone who applied for the Innovation Challenge. For those of you who were not selected, please look out for future opportunities including RESI San Diego (June) and RESI Boston (September).

Congratulations again to the selected RESI Europe Innovation Challenge companies – please see them below!

Therapeutics

 

Medical Device

Digital Health

Diagnostics

 

RESI’s Innovation Challenge Drove A Seed Round for This Medtech Startup – Interview with Yuan-Ren Cheng, COO of Heroic-Faith Medical Science

20 Feb

Yuan-Ren Cheng

An interview with Yuan-Ren Cheng, COO of Heroic-Faith Medical Science

– By Jessica Yang, Investor Research Analyst, LSN

Jessica Yang

International early-stage companies often seek cross-border investment opportunities and strategic partnerships. How do these companies start at the beginning? What can they do to meet global investors and expand beyond regionally available resources? LSN invites 10 different types of investors from across the globe to meet with early stage companies at the RESI conferences, allowing companies to take advantage of the chance to meet many investors who are a fit for them in one day. I recently spoke to Yuan-Ren Cheng, COO of Heroic-Faith Medical Science, who won second place in the RESI San Francisco 2019 Innovation Challenge and successfully raised their seed round. Heroic-Faith Medical Science is a Taiwan-based medical device company developing AI-powered respiratory monitor for the critical care medicine.

Jessica Yang (JY): Congratulations on raising your seed round! What is the recent progress of your company?

Yuan-Ren Cheng (YRC): Thank you! We raised our seed financing round of $2.96 million, and we are looking to raise our Series A round for $7 million this year. Our exciting story was that, before we attended RESI SF last year, we had secured only $900K for our seed round, and after RESI SF, we raised an extra of $2.06 M to make it $2.96 M in capital. We grew from 7-8 team members to 21 employees now. We also received our key patent in the US recently, and we expect our device to receive US FDA clearance this year.

JY: That’s amazing! How do you think RESI helped you?

YRC: I think applying for Innovation Challenge was an important decision for us. We got selected as a finalist at our first RESI and won second place. This helped us gain a lot of exposure via RESI’s newsletter announcement and promotion for the top 3 Innovation Challenge winners, and RESI’s media partners also promoted our company and technology. I think this make our respiratory monitor became more famous.

Besides some investors from Taiwan that we’d seen before, most investors are new to us. We got 11 confirmed meetings at our first RESI, including big firms like Siemens. Interestingly, though the VP of Business Development from Siemens told us we weren’t a fit for their investment focus, she still sees our product promising and further introduced her connections in the patient monitor area. This is the power of RESI! You get to meet right people in similar industries at RESI, and if you are well-prepared, you could get even more opportunities from these people. That’s why we always recommend other startups that we know to apply for Innovation Challenge and proactively attend RESI.

JY: What was your strategy of sending out meeting requests in the RESI partnering platform?

YRC: We sent 100+ meeting requests through the partnering platform. We especially increased our efforts in the week before RESI. We noticed that many investors start to lock down their schedules in the week prior to the conference, and that’s why we sent follow-up messages in the partnering system to grab their attention. Also, we regularly researched the partnering system for newly added investors. We searched and sorted hundreds of investors in the partnering system, then we prepared three kinds of executive summaries targeting different categories of investors that fit us. For example, we had executive summaries specifically for Medtech investors, Healthcare IT investors, and investors who are interested in pulmonary and cardiovascular sectors.

JY: How do you think Innovation Challenge is different from other startup competitions? What is the key advantage of Innovation Challenge?

YRC: Overall, I think RESI really organizes the Innovation Challenge very well! The RESI team provided instructive information to let everyone know the purpose of this competition is for startups to network with investors at their poster. It’s very straightforward and condensed, and the Innovation Challenge allows us to have interactions with many RESI attendees. We got tons of business cards and recognized new business opportunities because of the Innovation Challenge. This is crucial to us because we know whom to contact and with whom to follow up after the conference. After all, you need a list to send your emails with company updates.

Speaking of this, I will also recommend that two people from the same company attend RESI together, to allow one to focus on partnering meetings and the other to stay at the Innovation Challenge poster. I think this is the most productive way to attend RESI.

JY: In your seed round you also raised money from non-Taiwan investors, what is your suggestions to international companies who are currently fundraising?

YRC: I think one point is that international startups have to step out and attend global conferences like RESI. Looking for cross-border partnership isn’t an easy task. We know that some investors with geographical restrictions of their investments could be the barrier. But if you have strong arguments to convince other global investors with your actual execution and performance, I think there are always chances to get funding. For example, you really need to understand the unmet medical needs, digitize your company’s progress, and even find out the advantages from where you’re based. This is also why RESI is such a great platform that you can keep attending the conferences and following up with potential opportunities. Otherwise, you won’t know where to start and find targets that aren’t based in your region. You can also learn what other early-stage companies are developing in RESI and analyze your competitiveness.

JY: Thank you so much for sharing your story!

Established in June 2018, Heroic-Faith Medical Science Corp., LTD. is focused on the development of medical devices for the critical care medicine. The total annual spending on ICU care in North America in 2018 reaches $108 billion USD, being second only to cancer care which totals $158 billion USD, making it a key market that is marked by costly spending, as well as one that is open to new ideas. We hope to combine Taiwan’s advanced medical expertise with its cutting-edge electronics capabilities to develop break-through products, so that we can realize the ideal of our CEO, “Saving lives through innovation”, in the global market.

 

Two Ways to Highlight Your Startup at RESI in Paris

23 Jan

By Karen Deyo, Investor Research Analyst, LSN

On March 23rd, RESI will be coming to Paris for our second RESI in Europe. Life Science Nation (LSN) is offering early stage companies the chance to increase their exposure through two different startup showcases – the RESI Innovation Challenge and the new Featured Company Pitch Sessions.

Those who have attended RESI in the past are familiar with the RESI Innovation Challenge, which features the 30 most ‘investable’ companies, selected after a rigorous evaluation. These companies are evaluated based on innovativeness, marketability, stage of development and competitive edge, among other criteria, with selected companies presenting posters in the exhibit hall on the day of the conference. These companies compete for ‘investments’ of ‘RESI cash’ from their fellow attendees, with the top companies receiving prizes at the end of the day. Investors who attend RESI regularly are aware that companies selected to participate in the Innovation Challenge are selected based on merit, and many Innovation Challenge winners have successfully raised investments. The application deadline for the Innovation Challenge is February 21st, so make sure to apply here!

Meanwhile, the Featured Company Pitch Sessions are a new opportunity for companies to gain exposure to the investors attending RESI. For RESI Europe, companies can pay a fee of €1000 to pitch to a panel of investor judges as well as a broader audience of RESI attendees. Each hour slot will feature 4 companies pitching, with time after every pitch reserved for questions from the panel and audience. The application for the Featured Company Pitch Session is streamlined, with a rolling acceptance process. Pitching spots can fill up fast, so make sure to apply early.

Companies participating in both the Innovation Challenge and the Featured Company Pitch Sessions will be featured in the LSN Newsletter and the RESI Program Guide, with the Innovation Challenge winners announced after RESI.

 

RESI Innovation Challenge Featured Company Pitch Sessions
Rigorous application process, top 30 selected Streamlined application process, rolling acceptance
Poster display in the exhibit hall Pitch slot with 4 min pitch and 8 min Q&A
Competition with prizes Pitch to a dedicated feedback panel of investors
No fee to participate (beyond registration) Additional fee of €1000

RESI San Francisco 2020 Innovation Challenge Finalists Selected

19 Dec

By Claire Jeong, Director of Research, Asia BD, LSN

claire

We’re excited to announce the RESI San Francisco Innovation Challenge finalist companies (just in time for the holidays!). With RESI San Francisco being our most popular event, over 150 innovative companies across therapeutics, devices, diagnostics, and digital health applied to participate.

For those of you who are not familiar with the Innovation Challenge, this is a competition we organize at every RESI conference. Finalists will bring a posterboard showcasing their company and technology, which will be presented at a dedicated exhibition hall for the entire day. All attendees will be provided with “RESI Cash”, which they can use to “invest” in their favorite, most innovative companies. The Top 3 winners with the most RESI Cash will be announced during our cocktail reception.

Whether you will be attending RESI San Francisco or not, we highly recommend that you check out these companies through their clickable logos and see what they have to offer. Best of luck to the participating companies, and we look forward to seeing all of the incredible technologies next month on January 14th!

Therapeutics

Medical Devices

 

Diagnostics

Digital Health

Last Call for RESI SF Innovation Challenge Applications!

5 Dec

By Karen Deyo, Senior Investor Research Analyst, LSN

The deadline for applying to the RESI SF Innovation Challenge is tomorrow, Friday, Dec. 6th, and this is the last call for companies to submit their applications for consideration. The Innovation Challenge is a unique competition, where companies are selected using criteria such as innovativeness, stage of development, market size and opportunity and competitive landscape. The top companies, identified for their ‘investability,’ present posters in the exhibit hall on the day of the conference, competing for ‘investments’ of ‘RESI Cash’ from attendees to win prizes.

Participation in the Innovation Challenge can benefit finalists in many ways, including the increased exposure gained by the feature in the LSN Newsletter, the printed RESI Program Guide, as well as onsite signage at RESI. In addition, companies that actively seek ‘investments’ from attendees find that this can lead to many productive ad hoc meetings, furthering their fundraising campaigns in sometimes unexpected ways.

Click here to apply to the Innovation Challenge – good luck!

 

%d bloggers like this: